In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

View Content for:
Display:
  •          
Help with display options.
Results 1-14 of 14 for your search:
Drug:  quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine
Find trials that include:  Any drugs shown
Trial Status:  Active
Start Over
        Show
1.

Phase: Phase IV
Type: Biomarker/Laboratory analysis, Prevention
Status: Active
Age: 13 to 15 at first immunization
Sponsor: Other
Protocol IDs: HPV CSP01, NCT00956553
2.

Phase: Phase IV
Type: Prevention
Status: Approved-not yet active
Age: 13 to 15
Sponsor: Other
Protocol IDs: 37207, NCT01021904
3.

Phase: Phase IV
Type: Prevention
Status: Active
Age: 15 to 25
Sponsor: Pharmaceutical / Industry
Protocol IDs: 109823, NCT01031069
4.

Phase: Phase IV
Type: Prevention
Status: Active
Age: 11 to 17
Sponsor: Other
Protocol IDs: GardasilMerckGomez-Lobo, NCT01101750
5.

Phase: Phase IV
Type: Prevention
Status: Approved-not yet active
Age: 18 to 26
Sponsor: Other
Protocol IDs: CIHR-MOP-125949, IIS #38265, NCT01824537
6.

Phase: Phase III
Type: Supportive care, Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: UHKT-RLP/2011, 2011-002667-14, NCT01375868
7.

Phase: Phase III
Type: Biomarker/Laboratory analysis, Prevention
Status: Active
Age: 27 and over
Sponsor: NIAID
Protocol IDs: A5298, 11798, NCT01461096
8.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Prevention
Status: Active
Age: 13 to 26
Sponsor: NCI, Other
Protocol IDs: CDR0000685816, AMC-072, U01CA121947, NCT01209325
9.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Natural history/Epidemiology, Prevention
Status: Active
Age: 9 to 26
Sponsor: NCI, Other
Protocol IDs: 11034, NCI-2011-03654, 1R01CA166559, Merck-IISP#40083, NCT01492582
10.

Phase: No phase specified
Type: Health services research, Prevention
Status: Active
Age: 9 to 13
Sponsor: Other
Protocol IDs: 36448, NCT01096134
11.

Phase: No phase specified
Type: Health services research, Prevention, Screening
Status: Active
Age: 18 to 26
Sponsor: Other
Protocol IDs: 33249, NCT01133509
12.

Phase: No phase specified
Type: Biomarker/Laboratory analysis, Prevention
Status: Active
Age: 18 to 26
Sponsor: Other
Protocol IDs: 2011/02_Medicine, NCT01298869
13.

Phase: No phase specified
Type: Biomarker/Laboratory analysis, Natural history/Epidemiology
Status: Active
Age: 18 to 26
Sponsor: NCI
Protocol IDs: 2010C0114, P50CA105632, OSU-10096, NCT01299714
14.

Phase: No phase specified
Type: Natural history/Epidemiology
Status: Approved-not yet active
Age: 9 to 45
Sponsor: Other
Protocol IDs: V501-030-1, NCT01427777
New Search